LEVOCETIRIZINE DIHYDROCHLORIDE- levocetirizine dihydrochloride tablet, coated 
RUGBY LABORATORIES

----------

Drug Facts

Active ingredient (in each tablet)

Levocetirizine dihydrochloride USP, 5 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings

Do not use

  • if you have kidney disease
  • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine

Ask a doctor before use if you have

  • ever had trouble urinating or emptying your bladder

When using this product

  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery 

Stop use and ask doctor if

  • you have trouble urinating or emptying your bladder
  • an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

  • if breast-feding: not recommended
  • if pregnant: ask a health professional before use

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

adults 65 years of age and older
  • ask a doctor
adults and children 12-64 years of age
  • take 1 tablet (5 mg) once daily in the evening
  • do not take more than 1 tablet (5 mg) in 24 hours
  • 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
children 6-11 years of age
  • take 1/2 tablet (2.5 mg) once daily in the evening
  • do not take more than 1/2 tablet (2.5 mg) in 24 hours
children under 6 years of age
  • do not use
consumers with kidney disease
  • do not use

Other information

  • store between 20° and 25°C (68° and 77°F)
  • safety sealed: Bottle: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
  • Blister: Do not use if seal is broken or if individual blister unit is open or torn

Inactive ingredients

colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

Questions or comments?

Call 1-888-375-3784

Carton Label

Rugby

NDC 0536-1144-92


Compare to Xyzal®Allergy 24HR
active ingredient*

Original Prescription Strength
Levocetirizine
Dihydrochloride Tablets USP, 5 mg
Antihistamine

ALLERGY 24 HOUR

Relief of:

  • Sneezing • Runny Nose
  • Itchy Nose or Throat • Itchy, Watery Eyes

35 TABLETS

carton

Bottle Label

Rugby

NDC 0536-1144-92

Original Prescription Strength
Levocetirizine
Dihydrochloride Tablets USP
5 mg l Antihistamine

ALLERGY 24 HOUR

35 TABLETS

bottle

Blister Carton

Blister Carton

LEVOCETIRIZINE DIHYDROCHLORIDE 
levocetirizine dihydrochloride tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0536-1144(NDC:43598-735)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
levocetirizine dihydrochloride (UNII: SOD6A38AGA) (levocetirizine - UNII:6U5EA9RT2O) levocetirizine dihydrochloride5 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeOVALSize9mm
FlavorImprint Code L
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0536-1144-921 in 1 CARTON04/20/201801/31/2020
135 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:0536-1144-931 in 1 CARTON04/20/201801/31/2020
255 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:0536-1144-192 in 1 CARTON07/06/201804/30/2020
35 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA21037504/20/201804/30/2020
Labeler - RUGBY LABORATORIES (079246066)

Revised: 4/2025
Document Id: 11fff79e-3608-e9b1-8042-913f39d79022
Set id: b7ca3a57-8ae9-b464-a55d-a9e986734e7a
Version: 6
Effective Time: 20250429
 
RUGBY LABORATORIES